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Abstract
Aim: Shoulder pain and disability is a complication that can be seen frequently after implantable cardioverter defibrillator (ICD) 
implantation. The aims of this study were to determine the causes of shoulder problems and related factors in patients with ICD 
implantation and to investigate the effects of shoulder problems on quality of life and psychological status.
Material and Methods: A total of ninety-four consecutive patients (average age 59.38±10.75 years) who admitted to ICD follow 
up clinic were included in the study. Patients who had shoulder problems were referred to our physical therapy and rehabilitation 
outpatient clinic for further evaluation. The Shoulder Pain and Disability Index (SPADI), Short Form-36 (SF-36) and The Hospital 
Anxiety and Depression Scale (HADS) were used as the clinical assessment scales.
Results: Thirty-nine (41.5%) patients had shoulder complaints. The patients were divided into two groups according to presence of 
shoulder problem. The statistical analysis revealed no significant differences between the groups in terms of the socio-demographic 
and clinical characteristics. None of these characteristics was demonstrated as a risk factor for the development of shoulder 
problem (p>0.05). There were significantly lower SF-36 subgroup scores and higher HADS depression and anxiety scores in patients 
with shoulder complaints. The SPADI scores also showed significant correlations with shoulder pain VAS score, several subgroups 
of SF-36 and HADS scores (p<0.05).
Conclusion: Our study revealed that patients with shoulder complications had decreased quality of life and deteriorated psychological 
status. In patients with ICD, awareness should be increased in terms of shoulder problems and appropriate management strategies 
should be determined.
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INTRODUCTION
Implantable cardioverter defibrillator (ICD) has been 
the main treatment to prevent sudden cardiac death in 
patients with known ventricular tachycardia or fibrillation. 
ICD implantation is also recommended in selected 
patients who are at a high lifetime risk for ventricular 
tachycardia. ICD devices are mostly placed in the pectoral 
area of the non-dominant side either subcutaneously or 
subpectorally. The patients with ICD most likely may 
resume normal lifestyle but sometimes ICD implantation 
can be associated with complications which significantly 
influence the patient’s comfort. (1-4) These complications 
may be related to implantation procedure, type and size 
of the inserted generator, number of the leads implanted 
and presence of inappropriate shocks. (5) Incidence of 
serious adverse events like pneumothorax and cardiac 
arrest ranged from 1.2 to 1.4% (6).
 Shoulder problem is also an important complication that 
may occur after ICD implantation. Ignorance of shoulder 
complication may lead to pain, disability and decreased 
quality of life.  Several factors such as prolonged 
immobilization of the shoulder and physical trauma 
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caused by the generator and/or catheters may lead to 
this outcome. (2) There is no consensus on the limitation 
period of upper extremity movements after implantation. 
Some physicians suggest early mobilization, as well as 
some recommend to limit excess movements for a few 
weeks. The general approach is to extend the limitation 
period until the device and leads are fixed with fibrosis in 
the subcutaneous tissue, pectoralis muscles and/or the 
endocardium. But sometimes patients can keep this time 
longer with the concern of the dislocation of the ICD and/
or leads. (4,7,8 )
In the literature, the studies evaluating the shoulder 
problem as an ICD-related complication are limited. 
These studies mostly focused on the effects of ICD 
implantation on shoulder pain and disability. (1,2,4,9) The 
aims of this study were; to determine shoulder problems 
and related factors in patients with ICD implantation and 
to investigate the effects of shoulder problems on quality 
of life and psychological status.
MATERIAL and METHODS
A total of one hundred thirty-five consecutive patients with 
ICD were evaluated between February 2015 and January 
2016 in ICD follow up clinic of the cardiology department. 
Patients with the history of ipsilateral shoulder injury 
and surgery, previous shoulder disease, inflammatory 
rheumatic diseases, neuromuscular disease, and 
cognitive impairment were excluded. Therefore, 41 
patients were excluded and consequently 94 patients 
with ICD implantation were eligible for the study (Figure 
1). Patients who had shoulder problems were referred to 
our physical therapy and rehabilitation outpatient clinic 
for further evaluation and examination. All patients were 
questioned about socio-demographic characteristics, 
systemic diseases, drug use, smoking, place of 
implantation (subpectoral/subcutaneous), indication 
of ICD (ischemic and non-ischemic causes), ejection 
fraction of heart, duration of implantation, implantation 
related complications, and number of the electrodes. 
Detailed physical examination (inspection, palpation, 
muscle strength testing, and evaluation of shoulder range 
of motion with goniometer and special tests for shoulder), 
imaging methods [radiography (posterior-anterior and 
lateral view), ultrasonography] and laboratory assessment 
methods were applied when needed for diagnosis.  The 
severity of shoulder pain was assessed by visual analog 
scale (VAS). VAS scores ≤ 3 corresponded to mild, scores 
of 4-6 to moderate and scores ≥7 to severe pain. (10) Type 
of pain, factors that increase and decrease the pain and 
the treatment approaches were also questioned. This 
study was approved by the local ethics committee and we 
received informed consent from all patients. 
ICD implantation
All ICDs were implanted subcutaneously or subpectorally 
under local anesthesia in the cardiac catheterization 
laboratory. A 5–7 cm skin incision for the subcutaneous 
pocket is made in the infraclavicular area on the left side. 
Dissection is performed until pectoral facia with the use 
of electrocautery or blunt dissection. The dissection 
is enlarged to accommodate to the size of the battery. 
All leads were inserted via subclavian vein puncture or 
cephalic vein cut-down. Single-lead, two-leads or three-
leads (biventricular) ICD systems were used according to 
the clinical indication with respect to the left ventricular 
systolic function and present conduction abnormality of 
the heart. After proper placement, leads were tested for 
impedance and capture thresholds. Routine high output 
pacing was performed to be sure that phrenic nerve 
stimulation was absent. The leads were usually secured 
to pectoralis muscle with silk suture and then connected 
to the pulse-generator. In subpectoral implantation, 
the ICD device secured to the prepectoral facia or 
pectoralis muscle with non-absorbable suture. Skin and 
subcutaneous layers are then sutured with absorbable 
thread.
Evaluation of shoulder pain and disability
The Shoulder Pain and Disability Index (SPADI) is a 
self-administered instrument that assesses pain and 
functional status of the shoulder. SPADI contains 13-items 
to evaluate 2 subscales; 5-items measures the severity 
of an individual’s pain and 8-items measures disability 
in term of the degree of difficulty on various daily living 
activities. (11) It’s Turkish validity and reliability study 
was conducted by Bumin et al. (12) A 10 cm visual analog 
scale is used for each question and patients place a mark 
on it according to the severity of pain or difficulty. The 
total score is calculated by averaging the subscale scores. 
Higher scores indicate more severe pain and disability. 
(13)
Evaluation of health-related quality of life
Short Form-36 (SF-36) was used to assess the functional 
health and well-being of the patients. This questionnaire 
consists of 8 subscales including 36 questions. These 
scales investigate physical and social function, emotional 
and physical role, bodily pain, general health, vitality, and 
mental health. Each scale is transformed into a score 
between 0 and 100, and higher scores indicate better 
health status. (14)
Evaluation of Anxiety and Depressive Symptoms
The Hospital Anxiety and Depression Scale (HADS) is a 14-
item measure designed to evaluate depression, anxiety, 
and emotional distress. It has two subscales for anxiety 
and depression each containing 7-items. Items are rated 
on a 4-point Likert scale ranging from 0 to 3. The entire 
scale (emotional distress) ranges from 0 to 42 and higher 
scores indicate more symptom severity. 7 point is used as 
the cut-off score for depression subscale and 10 point for 
anxiety subscale. (15)
Statistical analysis
SPSS software package (version 20.0, SPSS Inc., Chicago, 
IL) was used for statistical analysis. Distributions of 
continuous variables were evaluated with the Shapiro-
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Wilk test. Continuous variables were presented as 
mean±standard deviation and discrete variables as median 
(minimum-maximum). Categorical variables expressed 
as number (n), and percentage (%) and the differences 
between the groups were compared with the chi-square 
test or Fisher Exact test. The significances of the difference 
in mean values between the two groups were analyzed 
with Student T-test. The linear relationship between SPADI 
scores and other clinical assessment scale scores were 
evaluated with Pearson correlation analysis.  A backward 
stepwise logistic regression analysis was used to 
assess independent predictors associated with shoulder 
problem development (dependent variable) in patients 
with ICD implantation. Variables which were found to be 
significantly different between the groups (patients with 
and without shoulder problem) were included as candidate 
risk factors to the multivariate logistic regression model 
and evaluated with univariate analysis. Variables, for which 
the unadjusted p-value was < 0.10 in univariate analysis 
were incorporated into the full model. The result of the 
power analysis according to the logistic regression model 
was 0.70.
RESULTS
The average age of all 94 patients with ICD implantation 
was 59.38±10.75 (37-88).  Thirty-nine patients (41.5%) had 
shoulder pain with/without limitation. The patients were 
divided into two groups according to presence of a shoulder 
problem. Ten patients had mild pain, 19 had moderate and 
10 had severe pain. Twelve patients had a limitation of the 
range of shoulder joint. The socio-demographic and clinical 
characteristics of the groups (39 patients with a shoulder 
problem and 55 patients without a shoulder problem) and 
the comparisons were shown in Table 1. The statistical 
analysis revealed no significant differences between the 
groups. We also performed multivariate logistic regression 
analysis and it was found that none of the clinical and 
socio-demographical characteristics was a risk factor for 
the development of shoulder problem in patients with ICD 
implantation after adjustment for confounding variables 
Table 1. Evaluation of socio-demographic and clinical characteristics in patients with and without shoulder problem
Variables shoulder problem+(n=39)                                    
shoulder problem-                                
(n=55)                                    p
Age, years                                                       59.3±10.4                                 59.4±11.1                                0.91
Gender, female/male 11/28(28.2/71.8)                      8/47(14.5/85.5)                       0.10       
BMI, kg/m2                                                      28.31±4.9                                 28.36±4.9                                0.91
Educational status, low/high 35/4 (89.8/10.2)                        47/8 (85.5/14.5)                     0.40
Marital status, married/unmarried                   34/5 (87.1/12.9)                        53/2 (96.4/3.6)                       0.07
Working status,working/not-working            31/8 (79.5/20.5)                        48/7 (87.3/12.7)                      0.31
Income, low /medium                                      9/30 (23.1/76.9)                       6/49 (10.9/89.1)                      0.11
Active  smoking 3 (7.7)                                       5 (9.1)                                    0.23
Comorbidities
DM 15 (38.5)                                  13 (23.6)                                 0.12        
HT                                                                    35 (89.7)                                  49 (89.1)                                 0.87        
Dislipidemia     17 (43.6)                                 29 (52.7)                                0.38
Place of implantation
Subpectoral / subcutaneous                              4/35(10.3/89.7)                        7/48(12.7/87.3)                       0.71
Indication of ICD 
Ischemic HF/non-ischemic HF                        23/16(59/41)                              33/22(60/40)                          0.68                   
Duration of implantation, month                     35.9±21.5                                   30.1±19.7                                0.10
Number of the electrodes (1/2)                        29/10(74.3/25.7)                        48/7(87.2/12.7)                       0.07
Values are mean± SD or n (%) Significance at P<.05
Abbreviations: BMI: Body Mass Index, DM: Diabetes Mellitus HF: Heart Failure HT: Hypertension
ICD: Implantable cardioverter defibrillator
The educational status  low: earlier than high school, high: high school and university
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(p>0.05). (Table 2). 
  Table 2. Pain assessment in patients with shoulder problems, n=39
Variables
Pain  VAS, mean±SD (min-max) 5.25±1.96 (1-8)




Duration of pain, month,  mean±SD 
(min-max)                      17.47±17.11 (1-72)
Acute, n(%)                                                                  4 (10.3)
Subacute, n(%)                                                            3 (7.7)
Chronic, n(%)                                                               32 (82.1)
Side of the body, n(%)
Unilateral 28 (69.2)
Bilateral                                                                          11 (28.2)
Quality of pain, n(%)
Sharp and stabbing                                                         13(33.3)
Dull 12 (30.8)
Aching                                                                               1(2.6)
Throbbing 3(7.7)
Burning                                                                             6(15.4)
Numbness and Tingling                                                 4(10.2)
Frequency, n(%)
Continuous                                                                      5(12.8)
 Intermittent                                                                    34 (87.2)
Type of pain, n(%)
Nosiseptive  33(84.6)
Neuropathic                                                                    2(5.12)
Mixed 4(10.3)
Presence of limitation, n(%) 12(30.8)
VAS: Visual analog scale
Among the patients with shoulder problems, the average 
pain VAS score was 5.25±1.96 and total SPADI score was 
42.53±21.34 (0.05-83.07) [pain subscale 48.86±20,69 
(0,12-88); disability subscale 37.5±24,71(0-95)].The 
detailed assessment of shoulder pain was shown in Table 
3. As a result of clinical evaluation; 32 of the patients (82%) 
had rotator cuff lesion, 21(53.8%) had degenerative joint 
disease, 17 (43.6%) had bicipital tendinitis and 9 of the 
patients (23%) had myofascial pain syndrome. Besides, 8 
patients (20.5%) had rotator cuff lesion, degenerative joint 
disease, and bicipital tendinitis together. Patients were 
also questioned whether they had received any treatment 
for shoulder pain and/or limitation.








(n=55)      
p
HADS
HADS-A                                                9.1±4.6            3.6±3.2                 <0.001
Anxiety+                                                14(35.9) 3(5.5)                 <0.001
HADS-D 8.2±4.1            5.1±3.2                <0.001
Depression+ 19(48.7)           12(21.8)           0.006
SF-36                  
Physical function                                   38.5±15.7        59.9±12.8          <0.001
Physical role limitation 32.8±10.5        72.1±10.1          <0.001
Bodily pain 54.1±22.8        84.2±20.5          <0.001
General health 42.8±17.5        56.2±15.4          <0.001
Vitality 38.3±18.1        66.7±17.1          <0.001
Social function 64.7±27.1        82.5±22.3        0.001
Emotional role 
limitation 41.8±13.74      83.0±10.6          <0.001
Mental health 52.4±21.3        81.09±16.2       <0.001
Values are mean+ SD or n (%)
HADS: The Hospital Anxiety and Depression Scale. SF-36: Short 
Form-36 
Table 4. Correlations between SPADI -total and clinical assessment 
scales
Variables r p
Shoulder pain VAS 0.76                 <0.001
HADS-A 0.53                 <0.001
HADS-D 0.31                   0.04
SF-36
Physical function                                   0.09                   0.56
Physical role limitation -0.009                 0.95
Bodily pain -0.46 0.003
General health -0.29                            0.06
Vitality -0.47                          0.003
Social function -0.41                      0.008
Emotional role limitation -0.33                 0.03
Mental health -0.57                  <0.001
HADS: The Hospital Anxiety and Depression Scale
SF-36:Short Form-36   VAS: Visual analog scale
It was revealed that 24 (61.5%) patients did not receive 
previous treatment, while 12 (30.7%) of them received only 
medical treatment.Our study also revealed significantly 
lower SF-36 subgroup scores and higher HADS depression 
and anxiety scores in patients with shoulder problems 
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(p<0,05). Taking 10 as a cut off point for HADS anxiety 
subscale and 7 point for depression; we found that the 
rate of the patients at risk for anxiety and depression were 
significantly higher in patients with shoulder problem. 
(Table 4) 
We also investigated the correlations of SPADI total 
scores with sociodemographic properties and clinical 
scale scores. We demonstrated significant relations 
between SPADI and shoulder pain VAS score, SF-36-
pain, vitality, social function, emotional role limitation and 
mental health subgroups , HADS anxiety and depression 
subgroups. (p<0.05) (Table 5). 
Table 5. The results of multivariate logistic regression analysis to 
detect the risk factors for the development of shoulder problems
Variables Odds Ratio %95 CI      p-value
Age 0.996 0.95-1.04 0.84
Sex 2.008 0.81-6.98 0.13
Place of implantation 0.634 0.15-2.66 0.53
Duration of implantation 0.847 0.56-1.28 0.43
Number of the electrodes 0.14 0.25-1.97 0.14
Figure 1. Flow diagram for subject enrollment in this study
DISCUSSION
Implantable cardioverter defibrillator is used in primary 
and secondary prevention of sudden cardiac death and its 
use has become widely increased in recent years. Shoulder 
pain and disability is a complication that can be seen 
frequently after implantation and adversely affects daily 
living activities. In our study, we aimed to determine the 
shoulder problems in patients with ICD implantation and 
examine the risk factors that may lead to the development 
of shoulder pain and/or limitation. In addition, we 
evaluated its effects on quality of life and psychological 
status. As a result, 41.5% of the patients with ICD  had 
shoulder complaints. Among the socio-demographic and 
clinical factors, none of them was found to be the risk 
factor for the development of shoulder problems. The 
patients with shoulder complications also had a markedly 
decreased level of quality of life and an increased rate and 
severity of anxiety and depression compared to patients 
without shoulder complications.  
In the literature, the number of studies examining shoulder 
problems after ICD implantation is limited. These studies 
usually focused on the occurrence and course of the 
shoulder pain and disability after implantation. (1,2,4,9) 
In Korte et al.’s study, shoulder problems and functions 
were evaluated within the first year of the subpectoral 
ICD implantation. At the third month assessment, they 
revealed that 60% of the patients had shoulder limitation 
which decreased during follow up with the rate was only 
8% at the 12 month visit. Similarly, they demonstrated that 
having ipsilateral pain was dropped from 62% to 10% at 
the one-year evaluation.(1) In another study, Diemberger 
et al. investigated the patients with subcutaneous ICD 
implantation during 3 months. In the evaluation of the 
quality of life, physical and mental component scores 
decreased at 2 weeks evaluation but physical component 
scores recovered in the 3rd month follow-up. Similarly, 
upper extremity functions improved and pain intensity 
decreased at 3rd month assessment. (2) These studies 
show that most of the parameters improved over time 
and the rate of disability in patients who underwent 
subcutaneous ICD implantation was lower compared to 
subpectoral implantation at the 3rd month evaluation. 
Our study has a cross-sectional design and does not 
examine the changes in shoulder pain and limitation at 
the post-implantation period.  We included patients with 
both subpectoral and subcutaneous ICD implantation and 
there was no significant difference between the groups of 
patients with and without shoulder problems in terms of 
implantation location.
In our study, we evaluated 94 consecutive patients referred 
to the ICD follow-up outpatient clinic and found that 
41.5% had shoulder complaints. The detailed evaluation 
showed that these complaints were due to rotator cuff 
lesion, degenerative joint disease, bicipital tendinitis, and 
myofascial pain syndrome and several combinations 
of these diseases. Although shoulder problems were 
frequently seen; the majority of patients (61.5%) had 
received no treatment for these complaints. Thirty percent 
of the patients received only medical treatment but no 
physical treatment approach was applied. Since patients 
prioritize cardiac problems in the post-implantation period, 
they do not care about shoulder problems and therefore do 
not receive adequate evaluation and treatment. However, 
as our study revealed, there was a significant deterioration 
in the quality of life and psychological status in patients 
with shoulder problems. This study also demonstrated 
that disability of shoulder (SPADI scores) was correlated 
with the severity of pain, anxiety and depression and 
several subgroups of SF-36.  Although the cause-effect 
relationship could not be established due to the design 
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of our study; we think that anxiety and depression may 
have triggered pain and disability, as well as shoulder 
disabilities, may have a negative effect on psychological 
status.  
In the literature, limited studies exist evaluating predictors 
of shoulder-associated problems in patients with ICD 
implantation. (1,2,4,9) Among them, Diemberger et 
al. revealed that post-procedure pain was the most 
important independent predictor of short-term shoulder 
impairment and  they emphasized the importance of 
good pain management. (2) In another study, Celikyurt 
et al. demonstrated that patients with three-leads ICD 
have significantly higher SPADI scores than patients with 
single-lead ICD and the number of leads correlated with 
pain, disability subscales, and total SPADI scores. They 
demonstrated that number of lead was the only predictor 
of shoulder pain and disability. (9) They explained this 
result with the greater dimensions of the three-leads ICDs 
compared to two-leads and single-lead ICDs. ICD devices 
could lead imbalances in shoulder complex muscles by 
the restriction of the pectoralis fascia with the effects of 
both volume and related inflammation of the device. (9,16) 
Differently, Korte et al. analyzed sex, age, body height, 
body weight, and body surface area as possible predictors 
of shoulder-associated problems after subpectoral ICD 
implantation but none of these factors was able to predict 
the shoulder complication. (1) Similarly, in our study, 
we couldn’t demonstrate significant risk factor for the 
development of shoulder problems. A limited number of 
participants may have contributed to this outcome.
Several mechanisms have been proposed for the 
development of shoulder problems in patients with 
ICD implantation.  The direct effects of ICD device and 
catheters and prolonged immobilization of the shoulder 
joint as a physician’s advice or patient’s fear of lead 
dislodgement may lead to this result. (2,4) Appropriate 
exercise programs including range of motion, stretching 
and strengthening should be applied to this patient group 
to prevent or to treat shoulder pain and disability. (17,18) In 
the literature, there is no consensus on the immobilization 
duration after implantation. Some physician suggest 
early mobilization, while others suggest a few weeks of 
movement limitation in order to wait for the formation of 
fibrosis around the device and lead to reduce the risk of 
dislodgement . (4,7,8)
Study limitations
Our study is a cross-sectional observational study and 
does not reveal a cause-effect relationship. The detailed 
evaluation of the shoulder had led to a limited number of 
patients admitted to this study. The majority of patients 
underwent implantation subcutaneously, and no patients 
had 3-lead ICD. These might cause limitation when 
evaluating risk factors for pain and disability. 
CONCLUSION
Shoulder problems were frequently seen in patients with 
ICD but they were not treated adequately. As shown in 
our study, patients with shoulder pain and limitation had 
decreased quality of life and deteriorated psychological 
status. In patients with ICD, awareness should be increased 
in terms of shoulder problems and appropriate treatment 
approaches should be determined. There is need for 
prospective studies in this area with larger populations to 
evaluate the effects of shoulder management  on quality 
of life and psychological status.
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